SEC Form 4 · accession 0000899243-15-006573
NovoCure Ltd · NVCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert J Mylod Jr.
Director
Period of report
Oct 7, 2015
Accepted (ET)
Oct 9, 2015 · 4:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645113
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Oct 7, 2015 | C | 148,114 | — | A | 148,114 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series H Convertible Preferred SharesF2,F1 | — | Oct 7, 2015 | C | 148,114 | D | — | — | Ordinary Shares | 148,114 | 0 | D |
Explanation of responses
- F1N/A.
- F2Pursuant to the issuer's memorandum & articles of association, all outstanding preferred shares of each series automatically converted into ordinary shares upon consummation of the issuer's initial public offering on October 7, 2015.